Park National Corp’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-16,502
| Closed | -$898K | – | 274 |
|
|
2022
Q2 | $898K | Buy |
16,502
+149
| +0.9% | +$8.11K | 0.04% | 161 |
|
|
2022
Q1 | $890K | Buy |
16,353
+20
| +0.1% | +$1.09K | 0.04% | 166 |
|
|
2021
Q4 | $900K | Sell |
16,333
-559
| -3% | -$30.8K | 0.04% | 158 |
|
|
2021
Q3 | $807K | Buy |
16,892
+80
| +0.5% | +$3.82K | 0.03% | 167 |
|
|
2021
Q2 | $837K | Sell |
16,812
-640
| -4% | -$31.9K | 0.04% | 164 |
|
|
2021
Q1 | $779K | Buy |
+17,452
| New | +$779K | 0.03% | 167 |
|
|
2019
Q1 | – | Sell |
-4,235
| Closed | -$202K | – | 327 |
|
|
2018
Q4 | $202K | Sell |
4,235
-281
| -6% | -$13.4K | 0.01% | 294 |
|
|
2018
Q3 | $226K | Sell |
4,516
-578
| -11% | -$28.9K | 0.01% | 306 |
|
|
2018
Q2 | $256K | Sell |
5,094
-3,285
| -39% | -$165K | 0.01% | 288 |
|
|
2018
Q1 | $410K | Buy |
8,379
+1,741
| +26% | +$85.2K | 0.02% | 231 |
|
|
2017
Q4 | $294K | Sell |
6,638
-674
| -9% | -$29.9K | 0.02% | 271 |
|
|
2017
Q3 | $371K | Buy |
7,312
+162
| +2% | +$8.22K | 0.02% | 234 |
|
|
2017
Q2 | $385K | Buy |
7,150
+2,099
| +42% | +$113K | 0.02% | 227 |
|
|
2017
Q1 | $266K | Buy |
5,051
+94
| +2% | +$4.95K | 0.02% | 280 |
|
|
2016
Q4 | $238K | Sell |
4,957
-452
| -8% | -$21.7K | 0.01% | 282 |
|
|
2016
Q3 | $291K | Buy |
5,409
+133
| +3% | +$7.16K | 0.02% | 253 |
|
|
2016
Q2 | $286K | Sell |
5,276
-260
| -5% | -$14.1K | 0.02% | 263 |
|
|
2016
Q1 | $281K | Buy |
5,536
+412
| +8% | +$20.9K | 0.02% | 263 |
|
|
2015
Q4 | $258K | Buy |
+5,124
| New | +$258K | 0.02% | 268 |
|